Diffuse pulmonary lesions caused by ANCA associated vasculitis: a case report

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2500096780

Enrollment

Unknown

Registered

2025-02-06

Start date

2025-02-20

Completion date

Unknown

Last updated

2025-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ANCA associated vasculitis

Interventions

Study Case:NA

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Those who meet the diagnosis of AAV; (2) Those who have good compliance and signed the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Combined with severe heart, liver, kidney and other primary diseases; (2) Those who are allergic to the components of the experimental drug.

Design outcomes

Primary

Measure	Time frame
Autoimmune vasculitis antibody profile quantification;	—

Secondary

Measure	Time frame
Complete blood count;Erythrocyte sedimentation rate;Inpatient biochemistry;Urine tests;Hypersensitive C-reactive protein;	—

Countries

China

Contacts

Public ContactJian Xiaoyun

Foshan of Hospital Traditiona Chinese Medicine

xyjxy200@126.com+86 138 0921 9815

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026